GI & Endoscopy

Douglas O. Faigel, MD, is a gastroenterologist and professor of medicine at Mayo Clinic in Scottsdale, Ariz. He is president-elect of the American Society for Gastrointestinal Endoscopy. He has previously served as chair of the Quality in Endoscopy Taskforce of…

Patients who continue to use proton pump inhibitors after an initial episode of Clostridium difficile infection remained at an elevated risk of CDI recurrence, according to a study published in JAMA Internal Medicine.

The future is difficult to predict, particularly in a field as mercurial as healthcare, but looking ahead is a necessary exercise in survival. Six gastroenterologists cast their eyes down the road and paint a picture of what the specialty could…

Here are seven news updates for gastroenterologists to know for March 6, 2015.

Here is a stock report on five publicly traded GI/endoscopy companies for March 2 to March 6.

The American Gastroenterological Association and American Society for Gastrointestinal Endoscopy have released updated recommendations for surveillance and management of dysplasia in patients with inflammatory bowel disease.

EndoChoice has closed $57 million in preferred equity financing.

This week, the FDA released an updated statement on duodenoscopes and associated risk of infection.  

Atilla Ertan, MD, is a professor of medicine in the gastroenterology, hepatology and nutrition division at the University of Texas Health Science Center in Houston. He is also the medical director of the Digestive Disease Center and Gastroenterology Center of…

Drug-induced acute liver failure is uncommon, and over-the-counter medications and dietary and herbal supplements, not prescription drugs, are its most common causes, according to a new study published in the current issue of Gastroenterology.